Literature DB >> 9810695

Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease.

B S Min1, N Nakamura, H Miyashiro, K W Bae, M Hattori.   

Abstract

Two new lanostane-type triterpenes, lucidumol A and ganoderic acid beta, were isolated from the spores of Ganoderma (G.) lucidum, together with a new natural one and seven that were known. The structures of the new triterpenes were determined as (24S)-24,25-dihydroxylanost-8-ene-3,7-dione and 3 beta,7 beta-dihydroxy-11,15-dioxolanosta-8,24(E)-dien-26-oic acid, respectively, by chemical and spectroscopic means. The quantitative analyses of 5 fruiting bodies, antlered form and spores of G. lucidum were performed by high performance liquid chromatography and demonstrated that ganoderic alcohol and acid contents were quite high in the spore. Of the compound isolated, ganoderic acid beta, (24S)-lanosta-7,9(11)-diene-3 beta,24,25-triol (called lucidumol B), ganodermanondiol, ganodermanontriol and ganolucidic acid A showed significant anti-human immunodeficiency virus (anti-HIV)-1 protease activity with IC50 values of 20-90 microM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9810695     DOI: 10.1248/cpb.46.1607

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  31 in total

1.  Analysis of triterpenoids in ganoderma lucidum using liquid chromatography coupled with electrospray ionization mass spectrometry.

Authors:  Min Yang; Xiaoming Wang; Shuhong Guan; Jiameng Xia; Jianghao Sun; Hui Guo; De-An Guo
Journal:  J Am Soc Mass Spectrom       Date:  2007-03-26       Impact factor: 3.109

Review 2.  Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling.

Authors:  Balraj Singh Gill; Prateek Sharma; Raj Kumar; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2015-12-30

3.  Lucidumol C, a new cytotoxic lanostanoid triterpene from Ganoderma lingzhi against human cancer cells.

Authors:  Yhiya M Amen; Qinchang Zhu; Hai-Bang Tran; Mohamed S Afifi; Ahmed F Halim; Ahmed Ashour; Amira Mira; Kuniyoshi Shimizu
Journal:  J Nat Med       Date:  2016-02-22       Impact factor: 2.343

4.  Apoptotic and Immune Restoration Effects of Ganoderic Acids Define a New Prospective for Complementary Treatment of Cancer.

Authors:  Faisal F Y Radwan; J Manuel Perez; Azizul Haque
Journal:  J Clin Cell Immunol       Date:  2011-12-11

5.  Two novel lanostane triterpenoids from Ganoderma sinense.

Authors:  Yin Qiao; Xian-min Zhang; Ming-hua Qiu
Journal:  Molecules       Date:  2007-08-23       Impact factor: 4.411

6.  Submerged fermentation production and characterization of intracellular triterpenoids from Ganoderma lucidum using HPLC-ESI-MS.

Authors:  Mei-lin Cui; Huan-yi Yang; Guo-qing He
Journal:  J Zhejiang Univ Sci B       Date:  2015-12       Impact factor: 3.066

Review 7.  Accessing biological actions of Ganoderma secondary metabolites by in silico profiling.

Authors:  Ulrike Grienke; Teresa Kaserer; Florian Pfluger; Christina E Mair; Thierry Langer; Daniela Schuster; Judith M Rollinger
Journal:  Phytochemistry       Date:  2014-11-06       Impact factor: 4.072

8.  Triterpenoids from the spores of Ganoderma lucidum.

Authors:  Bingji Ma; Wei Ren; Yan Zhou; Jinchuan Ma; Yuan Ruan; Chun-Nan Wen
Journal:  N Am J Med Sci       Date:  2011-11

9.  Quality Difference Study of Six Varieties of Ganoderma lucidum with Different Origins.

Authors:  Juan Lu; Jia-Zhang Qin; Ping Chen; Xi Chen; Ying-Zhi Zhang; Si-Jia Zhao
Journal:  Front Pharmacol       Date:  2012-04-09       Impact factor: 5.810

10.  Modulation of lanosterol synthase drives 24,25-epoxysterol synthesis and oligodendrocyte formation.

Authors:  Zita Hubler; Ryan M Friedrich; Joel L Sax; Dharmaraja Allimuthu; Farrah Gao; Adrianna M Rivera-León; Matthew J Pleshinger; Ilya Bederman; Drew J Adams
Journal:  Cell Chem Biol       Date:  2021-02-25       Impact factor: 9.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.